AI Enhanced-Smart Genome Editing: Integration of CRISPR-Cas9 with Artificial Intelligence for Cancer Treatment

The CRISPR-Cas9 genome editing system is a new technology that allows the modification of secret vital material using disruptions insertions or amendments of DNA sequence. It is an easy, widely accepted, and correct representation of gene modification. The potential for treating different genetic diseases is enormous. This paper discusses the latest approach to CRISPR-Cas9 integration with AI, aimed at improving efficacy, as well as the safety of cancer treatment. This paper highlights the cutting-edge integration of CRISPR- Cas9 with Artificial Intelligence (AI) to enhance the efficacy and safety of cancer treatment. Artificial intelligence is a simulation of human intelligence for computers, indicates the latest developments in the field, and mentions clinical trials' ability to help further the treatment of cancer and overcome current and upcoming challenges. Finally, the application of (AI) in the modification of the CRISPR/Cas9 system is highlighted. Taking case scenarios and futuristic approaches, this paper reveals excellent implementation initiatives by learning from the Clinical revolution together with human technology and aimed at a future in which new technologies improve patient outcomes without sacrificing ethics or putting patients first.